Table of Contents Table of Contents
Previous Page  265 / 330 Next Page
Information
Show Menu
Previous Page 265 / 330 Next Page
Page Background

265

19–22 APRIL, 2017, BARCELONA, SPAIN

MATERIAL AND METHODS

Eighty two patients under 18 years old with neurogenic bladder were evaluated, mostly by spinal

dysraphia. All patients were refractory to oral oxybutynin. We reinjected OnabotulinumtoxinA be-

tween 9 and 12 months, if there were clinical and / or urodynamic improvement after the third month

of the first injection. Otherwise, we indicated bladder augmentation.

RESULTS

We reinjected OnabotulinumtoxinA, two, three, four and five times: 20 cases, 7, 4 and one case,

respectively. In 51% average total urinary continence (zero-dry score) was achieved. In the first

and second injection there were significant increases in average cystometric capacity: 331 ml from

254 to (p: 0.007) and 257-367 ml (p: 0.014); respectively. The compliance of bladder wall in some

cases, improved, after the first injection: from 6.9 to 11.4 ml / cmH2O (p: 0.05). Mean detrusor

pressure at end of filling decreased from 41 to 38 cmH2O.

Detrusor overactivity (n: 22) was attenuated in 54.4% after the first injection. Any major adverse

effects were reported with reinjection.

Fifteen patients refractory to OnabotulinumtoxinA were intervened for bladder augmentation.

CONCLUSIONS

The treatment with OnabotulinumtoxinA achieved urinary continence in average 50%. The

Cystometric capacity increased significantly with the first two injections; although it was not accompa-

nied by a significant parallel decrease in intravesical pressures. The use of the OnabotulinumtoxinA

has been delayed the classic indication of bladder augmentation in refractory to anticholinergic

children.

S24-13 (P without presentation)

ARE UROLOGICAL ANOMALIES MORE COMMON

IN NEWBORNS WITH SPINA BIFIDA WITH UPPER LESIONS

COMPARED WITH LOWER?

Claire CULLEN

1

, Orla MCMAHON

2

, Emer ALDRIDGE

3

, Malcolm LEWIS

4

and Salvatore CASCIO

3

1) Temple Street Children’s University Hospital, Paediatric Surgery, Dublin, IRELAND - 2) Temple Street

Children’s University Hospital, Paediatric Urology, Dublin, IRELAND - 3) Temple Street Children’s University Hospital,

Paediatric Urology, Dublin, IRELAND - 4) Temple Street Children’s University Hospital, Paediatric Nephrology, Dublin,

IRELAND

PURPOSE

The large majority of newborns with myelodysplasia are born with a normal renal tract. However,

a small percentage of those born with neural tube defects have associated urological anomalies.

It is suggested that the level of spinal lesion correlates to specific renal anomalies. The aim of this

study is to examine the relationship between spinal dysraphism and renal anomalies.

MATERIAL AND METHODS

We retrospectively reviewed our database of children with spina bifida. Data analysis included

demographics, level of lesion, renal ultrasound and urological intervention. Spinal lesions were

separated into seven groups; encephalocele, thoracic, thoracolumbar, thoracosacral, lumbar,

lumbosacral and sacral.

RESULTS

381 patients were identified. 133 were excluded due to moving abroad, incomplete investigations

or being lost to follow up. Of the remaining 248 patients, there were 22 encephalocele, 8 thoracic,

17 thoracolumbar, 17 thoracosacral, 33 lumbar, 86 lumbosacral and 65 sacral.